scispace - formally typeset
P

Peter M. Silberfarb

Researcher at Dartmouth College

Publications -  31
Citations -  3024

Peter M. Silberfarb is an academic researcher from Dartmouth College. The author has contributed to research in topics: Cancer & Psychosocial. The author has an hindex of 20, co-authored 31 publications receiving 2958 citations. Previous affiliations of Peter M. Silberfarb include Memorial Sloan Kettering Cancer Center & Concord Hospital.

Papers
More filters
Journal ArticleDOI

Neuropsychologic Impact of Standard-Dose Systemic Chemotherapy in Long-Term Survivors of Breast Cancer and Lymphoma

Tim A. Ahles, +10 more
- 15 Jan 2002 - 
TL;DR: Data from this study support the hypothesis that systemic chemotherapy can have a negative impact on cognitive functioning as measured by standardized neuropsychologic tests and self-report of memory changes and suggest that only a subgroup of survivors may experience long-term cognitive deficits associated with systemic chemotherapy.
Journal ArticleDOI

Mental disorders in cancer patients: a study of 100 psychiatric referrals.

Peter M. Levine, +2 more
- 01 Sep 1978 - 
TL;DR: The importance of the mental status examination as a routine procedure in all cancer patients is stressed so that an organic brain syndrome will not be missed.
Journal ArticleDOI

Psychosocial Aspects of Neoplastic Disease: I. Functional Status of Breast Cancer Patients During Different Treatment Regimens

Peter M. Silberfarb, +2 more
- 01 Apr 1980 - 
TL;DR: The major findings indicated that physical disability did not necessarily relate to an increase in emotional disturbance, and adjuvant radiation therapy was a potent source of distress during primary cancer treatment, and at least one-third of all patients in each category reported needing help with household chores.
Journal ArticleDOI

Socioeconomic status and cancer survival.

David Cella, +9 more
- 01 Aug 1991 - 
TL;DR: In this paper, the additional predictive value of socioeconomic status (SES) was evaluated for patients with lung cancer, multiple myeloma, gastric cancer, pancreatic cancer, breast cancer, and Hodgkin's disease in eight Cancer and Leukemia Group B (CALGB) protocols.
Journal ArticleDOI

A brief POMS measure of distress for cancer patients.

David Cella, +5 more
- 01 Jan 1987 - 
TL;DR: The authors describe an 11-item short form of the Profile of Mood States' 58-item Total Mood Disturbance Score, derived from a sample of 619 adults with mixed cancer diagnoses, and replicated on a second sample of 295 lung cancer patients.